ArticleCancers2022

Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.

Javier Octavio Mejía-Hernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.